Article Information
History
- May 5, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Morihito Takita1,*,
- Tomoko Matsumura1,
- Kana Yamamoto1,2,3,
- Erika Yamashita2,
- Kazutaka Hosoda4,
- Tamae Hamaki2 and
- Eiji Kusumi1,2
- 1Department of Internal Medicine, Navitas Clinic Tachikawa, Tachikawa, Tokyo, Japan
- 2Department of Internal Medicine, Navitas Clinic Shinjuku, Shinjuku, Tokyo, Japan
- 3Department of Reproductive, Developmental and Aging Sciences, Graduate School of Medicine, University of Tokyo, Tokyo, Japan
- 4Department of Pediatrics, Navitas Clinic Tachikawa, Tachikawa, Tokyo, Japan
- ↵*Corresponding Author: Morihito Takita, Department of Internal Medicine, Navitas Clinic Tachikawa, Address: 3-1-1 Shibasaki, Ecute Tachikawa 4th floor, Tachikawa, Tokyo, 190-0023, Japan, Phone: +81-42-521-5334, Fax: +81-42-521-5329, Email: takita-ygc{at}umin.ac.jp
Posted May 05, 2020.
Preliminary Results of Seroprevalence of SARS-CoV-2 at Community Clinics in Tokyo
